InvestorsHub Logo
Replies to #1627 on Xtreme Plays

JLPTNG

11/26/12 8:55 AM

#1628 RE: Arbel #1627

$EKNL – Pre-Market action showing Bullish Breakout week ahead @xtremepicks_com

Pre-Market action is already showing EKNL is heading for a HUGE bullish week ahead. With major updates expected from the company this week investors are in for MAJOR gains.

EKNL closed Friday’s session up 10.37% to $0.415 and clearly the Bullish Harami Cross pattern confirmed EKNL is in solid bullish mode this week. With key monster updates expected from the company, investors are in for an XTREME week of XTREME gains.



Interesting enough EKNL is showing the same pattern and timing from our monster 2011 winner DROP (+83,000% gains) and is matching the exact same set up and pattern just prior to its HUGE bullish run.

After DROP‘s initial breakout run to $0.75, prices consolidated at support levels and DROP triggered a Bullish Harami Cross Pattern near the end of Nov 2011 and never looked back soaring from $0.30s to our target price of $1.25 in December.

EKNL just triggered a Bullish Harami Cross Pattern last week and confirmed with Friday’s session. With our $2 near term price target we are on the right track to hit this level and if history repeats just as we have seen with DROP, December will be a KEY breakout month for monster Gains – Making this week a prime week to add and accumulate for MEGA gains.

We are super excited of what’s to come this week and technicals confirmed a solid bullish reversal.

“Bullish Harami Cross Pattern”

http://www.candlesticker.com/images/31FIG.gif The Bullish Harami Cross Pattern is a major bullish reversal pattern and more significant than a regular Bullish Harami Pattern.

Bullish Harami Cross Pattern is a major upside reversal pattern. Short traders will not be wise to ignore the significance of a Harami cross just after a long black candlestick. Harami crosses point out to the bottoms.







The best part of this is that EKNL’s active float of 5.5 million shares will definitely make prices soar much faster and much higher than DROP

EKNL potential is is too good to pass up especially at these levels and we are committing to profile EKNL for the whole month and well into December bringing you the MONSTER updates and HUGE gains!

EKO International Corp.

Of course what really stands EKNL apart from everyone else is the relationships and key connections it has build so far.

imdTeaming up with iMDhealth.ca network just gave EKNL access to thousands of physician, diabetes education centers and health care providers for diabetics across Canada - practically becoming EKNL’s sales force for the treatment of Nueropathy and the FREMS FDA approved technology.



EKNL released monster news announcing EKO’s Dr. Ziemer of NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.” Dr. Paul Ziemer, world renowned for his expertise in the medical field joined the team at EKNL.





http://www.themayerinstitute.ca/wp-content/themes/starkers-for-storyboard/images/logo.pngEKNL launched first of many Clinics including recent announcement of launching clinics in the USA. These clinics will start to treat patients with their FDA approved FREMS technology that was also presented at the 13th annual Medical last month!



Also, Dr. Ziemer teamed up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit at the show.

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors now eying that multi-dollar target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY

ABOUT EKO INTERNATIONAL

EKO International Corp. is a holding company focused on growth through acq. Each acq. must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions favorable to itself.